Nurse Practitioner Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Brittney Browne

Nurse Practitioner, Acute Care Monroe, OH Nurse Practitioner

NPI 1710401047 CMS profile 10671691

610 Babbling Brooke Dr, Monroe, OH 45050

Open in the dashboard

General payments

$141,813

263 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Brittney Browne of Monroe, OH is reported in the CMS Open Payments database as having received $141,813 across 263 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $1,807 11
2023 General $57,183 90
2022 General $61,840 106
2021 General $20,983 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brittney Browne
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Brittney Browne were reported at $0. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Brittney Browne Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $20,983 $123 $38–$327 $132
2022 $61,840 $130 $44–$369 $149
2023 $57,183 $144 $49–$410 $160
2024 $1,807 $146 $48–$433 $164
2025 $0 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Kite Pharma, Inc. $73,432 98 payments
  2. E.R. Squibb & Sons, L.L.C. $42,814 71 payments
  3. Celgene Corporation $24,122 44 payments
  4. Pharmacyclics LLC, An AbbVie Company $204 10 payments
  5. Pharmacosmos Therapeutics Inc. $135 1 payment
  6. Janssen Biotech, Inc. $132 7 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $128 3 payments
  8. Adaptive Biotechnologies Corporation $124 1 payment
  9. Seattle Genetics, Inc. $118 2 payments
  10. AbbVie, Inc. $106 2 payments
  11. Other $498 24 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,480 55 payments
  2. Travel and Lodging $55,992 74 payments
  3. Food and Beverage $7,053 129 payments
  4. Consulting Fee $3,090 3 payments
  5. Education $198 2 payments
Products named General payments · program years 2021–2024
  1. REBLOZYL $42,247 69 payments
  2. Yescarta $41,133 51 payments
  3. ONUREG $19,534 30 payments
  4. ABECMA $705 2 payments
  5. IMBRUVICA Oncology $236 11 payments
  6. OPDIVO $215 2 payments
  7. MONOFERRIC $135 1 payment
  8. clonoSEQ $124 1 payment
  9. EPKINLY $106 2 payments
  10. IMBRUVICA Oncology $97 5 payments
  11. Other $699 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

263 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Acute Care in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record